Health Condition 1: L400- Psoriasis vulgaris
Conditions
Interventions
Intervention1: Psoramit Ointment: Clean the affected area and then apply the ointment over affected area twice daily for the period of 12 weeks.Topical application
Control Intervention1: Not Applicabl
Sponsors
The Himalaya Drug Company
Eligibility
Inclusion criteria
Inclusion criteria: Subject with symptoms of mild to moderate psoriasis with PASI score Subject diagnosed with Mild to moderate chronic plaque psoriasis with Palmoplantar psoriasis, Guttate psoriasis, Flexural psoriasis Age >18 to 65 years, both male and female subjects. Physician Global Assessment score of Patients willing to sign inform consent document.
Exclusion criteria
Exclusion criteria: Patients with Pustular psoriasis, Erythrodermic psoriasis and psoriatic arthritis Subjects treated with other medications / steroids. Significant medical problems such as uncontrolled hypertension / congestive heart failure or any other medication condition Pregnant & Breast feeding Women. History of ongoing, chronic or recurrent infectious disease / lymphoproliferative disease or history of malignancy of any organ system within the past 5 years. History of Alcohol or smoking abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of population achieving PASI 50 (Psoriasis area-and severity index) at End of study as compared to baseline visit.Timepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in Dermatology Life Quality Index (DLQI) at End of study as compared to Baseline visit. Improvement in Physicianâ??s Global assessment (PGA) scoring at End of Study as compared from baseline Visit. Subjects will be assessed for its safety during the study period.Timepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactDr Srikrishna H A
The Himalaya Drug Company
Outcome results
None listed